Literature DB >> 33854259

Skeletal involvement in Gaucher disease: extent of bone disease, splenic volume, and quality of life.

Ricardo Andrade Fernandes de Mello1, Melissa Bosi Nonato Mello2, Laís Bastos Pessanha1, Ana Paula Alves Fonseca1.   

Abstract

OBJECTIVE: To investigate the correlations among the extent of bone involvement, splenic volume, and quality of life in patients with Gaucher disease.
MATERIALS AND METHODS: This was a descriptive, prospective cross-sectional study of 18 patients with Gaucher disease who underwent 3-T magnetic resonance imaging of both femurs and the lumbar spine. Semiquantitative analyses were performed on the basis of the bone marrow burden (BMB) score. We looked for linear relationships among the variables splenic volume, quality of life score, and BMB score.
RESULTS: We identified a linear relationship between the BMB scores and splenic volume. The quality of life score showed no statistically significant relationship with splenic volume or the BMB score.
CONCLUSION: The linear relationship between the BMB score and the splenic volume indicates that the extent of bone disease is greater in individuals with splenomegaly. No correlation was found between the BMB and quality of life scores, illustrating the insidious and silent progression of Gaucher disease.

Entities:  

Keywords:  Gaucher disease; Hematologic diseases; Magnetic resonance imaging; Musculoskeletal system

Year:  2021        PMID: 33854259      PMCID: PMC8029931          DOI: 10.1590/0100-3984.2020.0014

Source DB:  PubMed          Journal:  Radiol Bras        ISSN: 0100-3984


  26 in total

Review 1.  Imaging and quantifying skeletal involvement in Gaucher disease.

Authors:  M Maas; L W Poll; M R Terk
Journal:  Br J Radiol       Date:  2002       Impact factor: 3.039

2.  Newer aspects of some interesting lipid storage diseases: Tay-Sachs and Gaucher's diseases.

Authors:  E Beutler
Journal:  West J Med       Date:  1977-01

3.  Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies.

Authors:  E Beutler; G L Dale
Journal:  Prog Clin Biol Res       Date:  1982

4.  Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.

Authors:  Pramod K Mistry; Neal J Weinreb; Paige Kaplan; J Alexander Cole; Andrea R Gwosdow; Thomas Hangartner
Journal:  Blood Cells Mol Dis       Date:  2010-11-26       Impact factor: 3.039

Review 5.  Gaucher's disease: a review.

Authors:  L E Morales
Journal:  Ann Pharmacother       Date:  1996-04       Impact factor: 3.154

6.  Bone density changes with enzyme therapy for Gaucher disease.

Authors:  Ehud Lebel; Altoon Dweck; A Joseph Foldes; Yosef Golowa; Menachem Itzchaki; Ari Zimran; Deborah Elstein
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

7.  Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.

Authors:  K Laudemann; L Moos; K E Mengel; A Lollert; J Reinke; M Brixius-Huth; D Wagner; C Düber; G Staatz
Journal:  Rofo       Date:  2015-07-22

8.  Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gaucher's disease.

Authors:  Robert F DeMayo; Andrew H Haims; Matthew C McRae; Ruhua Yang; Pramod K Mistry
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

Review 9.  Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease.

Authors: 
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

10.  Magnetic resonance imaging and BMB score in the evaluation of bone involvement in Gaucher's disease patients.

Authors:  Ricardo Andrade Fernandes de Mello; Melissa Bozzi Nonato Mello; Laís Bastos Pessanha
Journal:  Radiol Bras       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.